 Craig-Hallum Capital Group is acting as sole managing underwriter for the offering. Maxim Group LLC and The Benchmark Company, LLC are each acting as financial advisors to Nephros. Nephros intends to use the net proceeds of the offering for working capital and general corporate purposes. 